See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12th Annual Product Reference Guide
  • Insulin Syringe Chart
  • Insulin Pen Needles Chart
  • Fast-Acting Glucose
  • Sharps Disposal
  • Blood Glucose Meters Chart
  • Insulin Pumps Chart
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
Top Rated

Diabetes and Symlin Article Archives

December 2014

The Fear of Knowing

I picked up a pamphlet at my Endocrinologist’s office today that discusses the process of getting children screened for autoantibodies. These markers can signify the development of Type 1 diabetes up to ten years before it  takes hold. This fascinates and terrifies me in the same breath. I can find out if my children are prone to developing the disease I’ve survived for 16 years, but how will I handle the news if one of my children returns a positive result for having the markers of Type 1 diabetes?

comments 0 comments - Posted Dec 9, 2014

September 2012

Your Experience With Symlin

The following letter to the editor asks Diabetes Health subscribers to share their experiences with Symlin. If you use Symlin, please tell us about it in the “Comments” section. Have you had more success in managing your diabetes with Symlin?  How has your insurance company treated you regarding your prescription cost?

comments 7 comments - Posted Sep 27, 2012

June 2011

Amylin, JDRF Team to Test Symlin/Insulin Combo for Type 1

Amylin Pharmaceuticals has announced that it will collaborate with the Juvenile Diabetes Research Foundation to test a combination of Symlin and insulin in injectible form as a type 1 therapy.

comments 0 comments - Posted Jun 3, 2011

January 2011

Insulin's Partner: Amylin

Insulin has a companion, and it's called amylin. Amylin is a small hormone that is released along with insulin by the beta cells of the pancreas in response to a meal. When people are insulin-deficient, they are amylin-deficient as well. Amylin wasn't even discovered until 1970, and it was not until the 1990s that scientists began to figure out what amylin does. But they now know that it partners with insulin to help control blood sugar levels, each in its own way:

comments 1 comment - Posted Jan 28, 2011

November 2007

FDA Approves Symlin Pen, But Forbids Symlin Use Without Bolus Insulin

The Food and Drug Administration (FDA) just approved pre-filled pens for administering Symlin, which was previously available only in vials. The SymlinPen 60 delivers 15, 30, 45, or 60 micrograms per dose.

comments 9 comments - Posted Nov 14, 2007

October 2007

Symlin Promising as Weight Loss Drug
Symlin Promising as Weight Loss Drug

Symlin, or pramlintide, is synthetic amylin, a natural hormone that slows stomach emptying and leads to a feeling of fullness. Currently Symlin is used to dampen blood sugar rises in people with diabetes, but it's showing potential as a weight loss drug as well, according to a recent study.

comments 1 comment - Posted Oct 12, 2007

June 2007

Symlin Curtails Fast Food Binges in Weight Loss Study
Symlin Curtails Fast Food Binges in Weight Loss Study

As many of us know to our dismay, the desire to chow down fatty, sugary food can be very strong indeed. In a recent six-week study of 88 obese, non-diabetic men and women, Symlin, a synthetic hormone currently used to dampen diabetic blood sugar swings, was found to dampen those very desires.

comments 1 comment - Posted Jun 27, 2007

Ginger Graham, former CEO of Amylin
Ginger Graham, former CEO of Amylin

I recently had the privilege of interviewing Ginger Graham, the CEO who led Amylin during the launch of its two first-in-class medicines, Byetta and Symlin.  A fascinating woman with a very personal leadership style, she had the following to say about her past achievements and her future hopes.

comments 0 comments - Posted Jun 2, 2007

June 2005

FDA Approves Symlin
FDA Approves Symlin

On March 16, 2005, Amylin Pharmaceuticals, Inc., of San Diego, California, announced it had received FDA approval for Symlin (pramlintide acetate) injections to be used in conjunction with insulin to treat diabetes.

comments 0 comments - Posted Jun 1, 2005

©1991-2015 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.